Search

everythinglearnresearchcommunity

for

Search:↓

Human hair proteins can help blood clot when mixed in equal parts.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Platelet Rich Fibrin (PRF) is a safe, effective tool for tissue regeneration and healing in various medical fields.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Human cells in plasma-derived gels can potentially mimic hair follicle environments, improving hair regeneration therapies.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

A special gel with stem cells can create new hair follicles.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The authors suggest a method for hair transplantation in fibrosing alopecia pattern distribution to improve treatment outcomes and cover bald areas.

Platelet-rich fibrin helps in healing and rejuvenation but results vary and can take time.

Platelet Rich Fibrin improves healing and reduces acne scars by slowly releasing growth factors.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Type II spiral ganglion neurites avoid high concentrations of laminin and fibronectin.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Dermagraft and Dermalogen had a lot of granulation, while Alloderm, Integra, and ADM had good blood vessel growth for skin healing.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Angiogenin may help treat hair loss by reducing certain proteins in hair cells.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.